Fig. 8From: Cancer-associated fibroblast-derived gene signatures predict radiotherapeutic survival in prostate cancer patientsAssociation analysis of genes in CAF signatures with BCR, MET and immune checkpoints based on the gene expression data in GSE116918 dataset. A The expression levels of four randomly selected genes in the BCRFS-related CAF signature, such as ACPP, KCTD14, and THBS2 between BCR and non-BCR groups. B The expression of four randomly selected genes in the MFS-related CAF signature, such as HOPX, TMEM132A, ZNF467, and TMEM132A between MET and non-MET groups. C Correlation analysis of BCRFS-related CAF signature with immune checkpoints. CAF Cancer-associated fibroblast, BCR Biochemical recurrence, MET Metastasis, BCRFS Biochemical recurrence-free survival, MFS Biochemical recurrence-free survival, PSA Prostate specific antigenBack to article page